Evotec unit tapped by BARDA to fast-track antibody production for Ebola and Sudan viruses
Evotec (NASDAQ:EVO) announced today that its Seattle-based subsidiary, Just - Evotec Biologics, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to optimize the manufacturing of medical countermeasures against life-threatening filoviruses.










